HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jean-Marc Crance Selected Research

Jean-Marc Crance Research Topics

Disease

9Infection
03/2013 - 01/2002
5Smallpox (Variola)
01/2011 - 01/2005
5Vaccinia
03/2008 - 01/2005
3Poxviridae Infections
01/2011 - 12/2007
2Cowpox
01/2008 - 01/2007
1Encephalitis (Encephalitis, Rasmussen)
02/2012
1Bunyaviridae Infections
01/2011
1Necrosis
01/2010
1Superinfection
01/2009
1Carcinoma (Carcinomatosis)
01/2008
1Fever (Fevers)
07/2005
1Dengue (Dengue Fever)
01/2002
1Yellow Fever
01/2002

Drug/Important Bio-Agent (IBA)

5VaccinesIBA
02/2012 - 01/2005
3cidofovir (Vistide)FDA Link
07/2012 - 12/2007
3Smallpox VaccineFDA Link
03/2008 - 01/2005
3AntibodiesIBA
06/2007 - 01/2005
2Antiviral Agents (Antivirals)IBA
07/2012 - 04/2007
2Small Interfering RNA (siRNA)IBA
06/2009 - 01/2008
2ST-246IBA
01/2008 - 01/2007
2Immunoglobulins (Immunoglobulin)IBA
12/2005 - 01/2005
1Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
03/2013
1Carbon MonoxideIBA
02/2012
1PhospholipidsIBA
01/2011
1Ribavirin (Virazole)FDA LinkGeneric
01/2011
11,2-dipalmitoylphosphatidylglycerol (DPPG)IBA
01/2011
1InterleukinsIBA
01/2010
1Interleukin-6 (Interleukin 6)IBA
01/2010
1Interleukin-8 (Interleukin 8)IBA
01/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2010
1Messenger RNA (mRNA)IBA
01/2009
1DNA (Deoxyribonucleic Acid)IBA
01/2009
1NucleoproteinsIBA
07/2005
1Neutralizing AntibodiesIBA
01/2005
1Heparitin Sulfate (Heparan Sulfate)IBA
01/2002
1Heparin (Liquaemin)FDA LinkGeneric
01/2002